Precedent Wealth Partners
RMD icon

Precedent Wealth Partners’s ResMed RMD Stock Holding History

Precedent Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$277K Buy
+1,253
New +$273K 0.04% 170

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Precedent Wealth Partners's RMD Position: Q3 2026 in Review

Precedent Wealth Partners opened a new position in ResMed (RMD) in Q3 2026: 1,253 shares worth $277K. The stake represents 0.04% of the portfolio and ranks #170 among its holdings.

741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Precedent Wealth Partners held 1,253 shares of ResMed worth $277K as of Q3 2026.
  • ResMed was a new Precedent Wealth Partners position in Q3 2026.
  • ResMed made up 0.04% of Precedent Wealth Partners's portfolio in Q3 2026, its #170 holding.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Precedent Wealth Partners's 13F filing for Q3 2026, filed 21 Oct 2026.